Since Clinicaprofiled Xeltis in Medtech Ventures in October 2012, the biodegradable cardiovascular implant developer has been keeping busy. In February, the Swiss firm completed enrolment in a small feasibility study, marking the first time its technology has been implanted in humans.
Zurich-based Xeltis has developed a biodegradable scaffold that encourages the formation of natural heart tissue, and then degrades over time,...